Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carr

Showing results (1251-1260 of 1,288) with videos related to

Pageof 129
Sort By:
Human Molecular Genetics|November 10, 2011
Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defectsKamron Khan, Clare V Logan, Martin McKibbin, et al.
Nature Genetics|November 22, 2011
Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)Clare V Logan, Barbara Lucke, Caroline Pottinger, et al.
Plos One|November 14, 2013
An integrated model of the transcriptome of HER2-positive breast cancerKrishna R Kalari, Brian M Necela, Xiaojia Tang, et al.
Plos Genetics|September 19, 2014
HEATR2 plays a conserved role in assembly of the ciliary motile apparatusChristine P Diggle, Daniel J Moore, Girish Mali, et al.
JCO Oncology Practice|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
American Journal of Human Genetics|August 21, 2012
Mutations in C4orf26, encoding a peptide with in vitro hydroxyapatite crystal nucleation and growth activity, cause amelogenesis imperfectaDavid A Parry, Steven J Brookes, Clare V Logan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 28, 2021
Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer SubcommitteeRobert W Mutter, J Isabelle Choi, Rachel B Jimenez, et al.
Journal of Medicinal Chemistry|April 4, 1998
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazineA K Mallams, R R Rossman, R J Doll, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Science (New York, N.Y.)|April 10, 1981
Encounter with saturn: voyager 1 imaging science resultsB A Smith, L Soderblom, R Beebe, et al.
Pageof 129

Showing results (1251-1260 of 1,288) with videos related to

Sort By:
Pageof 129
Human Molecular Genetics|November 10, 2011
Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defectsKamron Khan, Clare V Logan, Martin McKibbin, et al.
Nature Genetics|November 22, 2011
Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)Clare V Logan, Barbara Lucke, Caroline Pottinger, et al.
Plos One|November 14, 2013
An integrated model of the transcriptome of HER2-positive breast cancerKrishna R Kalari, Brian M Necela, Xiaojia Tang, et al.
Plos Genetics|September 19, 2014
HEATR2 plays a conserved role in assembly of the ciliary motile apparatusChristine P Diggle, Daniel J Moore, Girish Mali, et al.
JCO Oncology Practice|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
American Journal of Human Genetics|August 21, 2012
Mutations in C4orf26, encoding a peptide with in vitro hydroxyapatite crystal nucleation and growth activity, cause amelogenesis imperfectaDavid A Parry, Steven J Brookes, Clare V Logan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 28, 2021
Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer SubcommitteeRobert W Mutter, J Isabelle Choi, Rachel B Jimenez, et al.
Journal of Medicinal Chemistry|April 4, 1998
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazineA K Mallams, R R Rossman, R J Doll, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Science (New York, N.Y.)|April 10, 1981
Encounter with saturn: voyager 1 imaging science resultsB A Smith, L Soderblom, R Beebe, et al.
Pageof 129